This list of the world’s top cannabis scientists was inspired by the passing of Raphael Mechoulam, who undoubtedly influenced every cannabis scientist detailed here. Supporting those who work in the science of cannabis is critical to overturning decades of stigma, pushing regulators to adopt cannabis science, and helping people understand the therapeutic and medical value of cannabinoids and other phytochemicals found in cannabis.
The cannabis scientists and researchers listed here are in random order, and, if readers want to add to this list, they can do so using our CONTACT PAGE.
Austin Sheppe, Ph.D.
*Ph.D. in Microbiology and Cell Science from the University of Florida
*Cannabis Genomics and Breeding
PUBLICATIONS BY AUSTIN SHEPPE, Ph.D.:
Yersinia pseudotuberculosis YopJ Limits Macrophage Response by Downregulating COX-2-Mediated Biosynthesis of PGE2 in a MAPK/ERK-Dependent Manner
Roles of Eicosanoids in Regulating Inflammation and Neutrophil Migration as an Innate Host Response to Bacterial Infections
Antigen-encapsulating host extracellular vesicles derived from Salmonella-infected cells stimulate pathogen-specific Th1-type responses in vivo
Exosomes released by breast cancer cells under mild hyperthermic stress possess immunogenic potential and modulate polarization in vitro in macrophages
PGE2 Augments Inflammasome Activation and M1 Polarization in Macrophages Infected With Salmonella Typhimurium and Yersinia enterocolitica
tRNA-dependent alanylation of diacylglycerol and phosphatidylglycerol in Corynebacterium glutamicum.
Ethan Russo, M.D.
*M.D. from UMass Chan Medical School
*Certified Neurologist by American Board of Psychiatry and Neurology
*Cannabis entourage researcher, child neurology specialist, formerly of GW Pharmaceuticals, now CReDO Science
PUBLICATIONS BY ETHAN RUSSO, M.D.:
Even high doses of oral cannabidiol do not cause THC-like effects in humans.
Beyond cannabis: Plants and the endocannabinoid system
Cannabidiol claims and misconceptions
Clinical endocannabinoid deficiency reconsidered: Current research support the theory in migraine, fibromyalgia, irritable bower, and other treatment-resistant syndromes.
Current therapeutic cannabis controversies and clinical trial design issues.
The Cannabis sativa versus Cannabis indica debate: An interview with Ethan Russo, MD
Current status and future of cannabis research
Synthetic and natural cannabinoids: The cardiovascular risk.
Cannabis Inflorescence: Standards of Identity, Analysis and Quality Control
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use
*BS, Bioengineering, Arizona State University
*Cannabis Analytical Testing, Orange Photonics
Mark Scialdone, Ph.D.
*Ph.D. in Chemistry from Wayne State University
*Long time research scientist for DuPont
PUBLICATIONS BY MARK SCIALDONE, Ph.D.:
Hydrogenation of Naturally-Derived Nepetalactone as a Topical Insect Repellent
The Identification of Δ-8 Tetrahydrocannabinolic Acid (Δ-8-THCA) by NMR and LCMS Techniques
Hydrogenated Cannabis Oil
Lysinol: A Renewably Resourced Alternative to Petrochemical Polyamines and Aminoalcohols
Dihydronepetalactones Deter Feeding Activity by Mosquitoes, Stable Flies, and Deer Ticks
Repellency of Hydrogenated Catmint Oil Formulations to Black Flies and Mosquitoes in the Field.
Antimicrobial β-peptoids by a Block Synthesis Approach
Trans- Cyclopropyl β-Amino Acid Derivatives via Asymmetric Cyclopropanation Using A (Salen) Ru (II)- Catalyst
Resin-to-Resin Acyl and Aminoacyl Transfer Reactions Using Oxime Supports
Solid-phase Synthesis of Linear and Cyclic Amino Acid-Derived Urea Peptidomimetics
A New Resin for the Solid-Phase Synthesis of Ureas via Thermolytic Cleavage of Oxime-Carbamates
Octafunctionalized Polyhedral Oligosilsesquioxanes as Scaffolds: Synthesis of Peptidyl Silsesquioxanes
Diisocyanates as scaffolds for combinatorial libraries. The solid-phase synthesis of bis-ureas from polymer-supported diisocyanates
Shabnam Sarshar, Ph.D.
*Doctor of Pharmaceutical Biology and Phytochemistry from University of Munster
*Cannabis Phytochemical Researcher
PUBLICATIONS BY SHABNAM SARSHAR, Ph.D.:
Plants of the Gods and Their Recently Discovered Therapeutic Applications.
Traditionally used medicinal plants against uncomplicated urinary tract infections: Hexadecyl coumaric acid ester from the rhizomes of Agropyron repens (L.) P. Beauv. with antiadhesive activity against uropathogenic E. coli.
*Master of Science in Biological Sciences from Chicago State University
*Certified Professional Interpener
*Cannabis/Environmental Biology Researcher
Codi Peterson, PharmD
*Doctor of Pharmacy from Duquesne University
*Pediatric Pharmacist and cannabinologist
Shawna Vreeke, Ph.D.
*Ph.D. in Organic Chemistry from Portland State University
*Cannabis Toxicology and Risk Assessment
PUBLICATIONS BY SHAWNA VREEKE, Ph.D.:
A First-Tier Framework for Assessing Toxicological Risk from Vaporized Cannabis Concentrates
A Simple Predictive Model for Estimating Relative E-cigarette Toxic Carbonyl Levels
Dihydroxyacetone levels in electronic cigarettes: Wick temperature and toxin formation.
E-cigarettes can emit formaldehyde at high levels under conditions that have been reported to be non-averse to users
Triacetin Enhances Levels of Acrolein, Formaldehyde Hemiacetals, and Acetaldehyde in Electronic Cigarette Aerosols
John MacKay, Ph.D.
*Ph.D. in Chemistry from the University of Vermont
*Cannabis Chemist, R&D
*Decades of cannabis research
Susan Trapp, Ph.D.
*Ph.D. in Biochemistry from the University of Maryland
*Cannabis Terpene Researcher
PUBLICATIONS BY SUSAN TRAPP, Ph.D.:
Genomic Organization of Plant Terpene Synthases and Molecular Evolutionary Implications
Defensive Resin Biosynthesis in Conifers
Draft genome sequence of Mentha longifolia and development of resources for mint cultivar improvement
Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma
Molecular signatures of neoadjuvant endocrine therapies for breast cancer: characteristics of response or intrinsic resistance, Breast Cancer Research and Treatment
*Cannabis IPM Researcher
PUBLICATIONS BY MATTHEW GATES:
Integrated Pest Management against Arthropod Pests of Cannabis sativa in the United States of America
Viral diseases of Hemp (Cannabis sativa)
Marijuana Garden Saver: A field guide to identifying and correcting cannabis problems
The Molecular Grammar of Plants and its Genetic Basis in Terpene Biosynthesis
Paul Muchowski, Ph.D.
*Ph.D. in Biological Structure from the University of Washington
*Cannabis neurodegenerative diseases scientist
PUBLICATIONS BY PAUL MUCHOWSKI, Ph.D.:
Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice
Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain
Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington’s disease
Mutant huntingtin impairs immune cell migration in Huntington disease
Kynurenines in the mammalian brain: when physiology meets pathology.
Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context
Bone marrow transplantation confers modest benefits in mouse models of Huntington’s disease
Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration
Hsp70 and Hsp40 functionally interact with soluble mutant huntingtin oligomers in a classic ATP-dependent reaction cycle
Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo
Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment.
Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington’s disease.
A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease
Modulation of neurodegeneration by molecular chaperones.
Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer
Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein
Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment
Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils
Small heat-shock proteins and their potential role in human disease
ATP-enhanced molecular chaperone functions of the small heat shock protein human alphaB crystallin
Human alphaB-crystallin. Small heat shock protein and molecular chaperone
Dustin Sulak, Ph.D.
*Doctorate of Osteopathy from Arizona College of Osteopathic Medicine
*Medical Cannabis Doctor
*Specializes in treating refractory conditions with medical cannabis.
PUBLICATIONS BY DUSTIN SULAK, Ph.D.:
Current and Future Status of Cannabis Research.
A Survey on the Effect That Medical Cannabis Has on Prescription Opioid Medication Usage for the Treatment of Chronic Pain at Three Medical Cannabis Practice Sites
The current status of artisanal cannabis for the treatment of epilepsy in the United States.
Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer
Education, Knowledge, and Practice Characteristics of Cannabis Physicians: A Survey of the Society of Cannabis Clinicians.
Daniela Vergara, Ph.D.
*Ph.D. in Evolutionary Biology from Indiana University Bloomington
*Cannabis Researcher: Genomics, Breeding
PUBLICATIONS BY DANIELA VERGARA, Ph.D.:
Widely assumed phenotypic associations in Cannabis sativa lack a shared genetic basis
Anna Schwabe, Ph.D.
*Ph.D. in Biological Education from University of Northern Colorado
*Cannabis educator and R&D specialist
*Cannabis genetics expert
PUBLICATIONS BY ANNA SCHWABE, Ph.D.:
Comparative Genetic Structure of Cannabis sativa Including Federally Produced, Wild Collected, and Cultivated Samples
Genomic Evidence That Governmentally Produced Cannabis sativa Poorly Represents Genetic Variation Available in State Markets
Research grade marijuana supplied by the National Institute on Drug Abuse is genetically divergent from commercially available Cannabis
Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: Implications for a budding industry
Weeding out the truth behind Cannabis strain names: Genetic analyses confirm strain names are inconsistent and need regulation
Bruce Bugbee, Ph.D.
*Ph.D. in Environmental Plant Physiology
*Professor of Plants, Soils, and Biometeorology at Utah State University
Matthew Indest, Ph.D.
*Ph.D. in Plant, Environmental, and Soil Sciences from Louisiana State University
*Technical Director of Agronomy and Plant Improvement at Curaleaf
Patrick Woods, Ph.D.
*Ph.D. in Plant Breeding, Genetics, and Genomics from Colorado State University
*Cannabis genetics, genomics, breeding expert
PUBLICATIONS BY PATRICK WOODS, Ph.D.:
Genome-wide polymorphism and genic selection in feral and domesticated lineages of Cannabis sativa
Root Pulling Force Across Drought in Maize Reveals Genotype by Environment Interactions and Candidate Genes
Quantitative Trait Loci Controlling Agronomic and Biochemical Traits in Cannabis sativa
Jordi Petit Pedró, Ph.D.
*Ph.D. in Plant Breeding from Wageningen University & Research
Christoper Grassa, Ph.D.
*Ph.D. in Domestication from Harvard University
*Cannabis genomics expert
*Master of Science in Medical Cannabis Therapeutics from Pacific College
*Cannabis Nurse – CHPN, RN
*Master of Science in Engineering Management from Tufts University
*Cannabis analytical testing expert
PUBLICATIONS BY DYLAN WILKS:
Challenges of an automated spectral responsivity characterization system
Lower Resolution Infrared (IR) Spectroscopy Can Provide Higher Performance for Quantitative Biodiesel Measurements
Synthetic Jet Fuel Blend Analysis using Mid-Infrared Spectroscopy
The impact of blending techniques, feedstock choice, and analytical techniques on biodiesel blend accuracy
Jeff Rawson, Ph.D.
*Ph.D. in Chemistry from Duke University
*Cannabis science advocate and researcher
Miyabe Shields, Ph.D.
*Ph.D. in Pharmaceutical Sciences from Northeastern University
PUBLICATIONS BY MIYABE SHIELDS, Ph.D.:
Biochemical and Proteomic Characterization of Recombinant Human α/β Hydrolase Domain 6.
Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment.
Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.
Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys.
Allyn Howlett, Ph.D.
*Ph.D. in Biochemical Neuropharmacology from Rutgers University
*Professor at Wake Forest University Baptist Medical Center
*Discoverer of CB1 receptor for cannabinoid agonists
PUBLICATIONS BY ALLYN HOWLETT, Ph.D.:
Increased Angiotensin II Contraction of the Uterine Artery at Early Gestation in a Transgenic Model of Hypertensive Pregnancy Is Reduced by Inhibition of Endocannabinoid Hydrolysis
Alterations in the Medullary Endocannabinoid System Contribute to Age-related Impairment of Baroreflex Sensitivity
Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism
Steric Trigger as a Mechanism for CB1 Cannabinoid Receptor Activation
Early phytocannabinoid chemistry to endocannabinoids and beyond
WIN55212-2 Docking to the CB1 Cannabinoid Receptor and Multiple Pathways for Conformational Induction
Endocannabinoid System in Pregnancy Maintenance and Labor: A Mini-Review
Endocannabinoids and Reactive Nitrogen and Oxygen Species in Neuropathologies
Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease
Acute Depletion of D2 Receptors from the Rat Substantia Nigra Alters Dopamine Kinetics in the Dorsal Striatum and Drug Responsivity
The Spicy Story of Cannabimimetic Indoles
The Endocannabinoid System and Oligodendrocytes in Health and Disease
Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure
WIN55212-2 Modulates Intracellular Calcium via CB1 Receptor-Dependent and Independent Mechanisms in Neuroblastoma Cells
Cannabinoid receptor interacting protein 1a interacts with myristoylated Gαi N terminus via a unique gapped β-barrel structure
CB1 Cannabinoid Receptors Stimulate Gβγ-GRK2-Mediated FAK Phosphorylation at Tyrosine 925 to Regulate ERK Activation Involving Neuronal Focal Adhesions
Thyroid Effects on Adenosine 3′,5′-Monophosphate Levels and Adenylate Cyclase in Cultured Neuroblastoma Cells
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression
Vincenzo di Marzo, Ph.D.
*Ph.D. in Biochemistry and Pharmacology from Imperial College London
*Canada Excellence Research Chair
PUBLICATIONS BY VINCENZO DI MARZO, Ph.D.:
The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity
New approaches and challenges to targeting the endocannabinoid system
Hemp seed significantly modulates the endocannabinoidome and produces beneficial metabolic effects with improved intestinal barrier function and decreased inflammation in mice under a high-fat, high-sucrose diet as compared with linseed
Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer’s disease
Endocannabinoids: A unique opportunity to develop multitarget analgesics
Pal Pacher, Ph.D.
*Ph.D. in Cardiovascular Pharmacology from Semmelweis University
*Tenured Senior Investigator, National Institutes of Health
PUBLICATIONS BY PAL PACHER, Ph.D.:
Interplay of liver-heart inflammatory axis and cannabinoid 2 receptor signaling in an experimental model of hepatic cardiomyopathy.
Disruption of Renal Arginine Metabolism Promotes Kidney Injury in Hepatorenal Syndrome in Mice.
Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly
PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis.
Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.
A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.
Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.
Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats.
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.
Nitric oxide and peroxynitrite in health and disease.
Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.
Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy.
NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.
The endocannabinoid system as an emerging target of pharmacotherapy.
Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.
Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.
Cannabinoids cool the intestine.
Ziva Cooper, Ph.D.
*Ph.D. in Biopsychology from the University of Michigan
*Director of the UCLA Center for Cannabis and Cannabinoids
PUBLICATIONS BY ZIVA COOPER, Ph.D.:
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability
Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073
Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective
Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers
The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research
Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.
Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal
Novel Pharmacologic Approaches to Treating Cannabis Use Disorder
Investigation of sex-dependent effects of cannabis in daily cannabis smokers
A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers
Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.
Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts.
Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers
Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.
Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.
Marijuana’s dose-dependent effects in daily marijuana smokers.
Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.
Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status.
Effects of menstrual cycle phase on cocaine self-administration in rhesus macaques.
Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances
Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.
Opioid antagonism enhances marijuana’s effects in heavy marijuana smokers.
Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts
Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.
Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.
Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.
Sex-dependent effects of cannabis-induced analgesia
Carrie Cuttler, Ph.D.
*Ph.D. in Cognitive Science from the University of British Columbia
PUBLICATIONS BY CARRIE CUTTLER, Ph.D.:
Blunted stress reactivity in chronic cannabis users
Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU)
Symptoms of obsessive-compulsive disorder predict cannabis misuse
A cross-sectional survey of medical cannabis users: Patterns of use and perceived efficacy
Sex differences in cannabis use and effects: A cross-sectional survey of cannabis users
Mechanisms underlying the link between cannabis use and prospective memory
Jerry King, Ph.D. (The King of Cannabis Extraction)
*Ph.D. in Analytical Chemistry from Northeastern University
*Cannabis R&D expert
Riley Kirk, Ph.D.
*Ph.D. in Pharmaceutical Sciences from University of Rhode Island
*Cannabis educator and research scientist
PUBLICATIONS BY RILEY KIRK, Ph.D.:
Screening the PRISM Library against Staphylococcus aureus Reveals a Sesquiterpene Lactone from Liriodendron tulipifera with Inhibitory Activity
New Micropeptins with Anti-Neuroinflammatory Activity Isolated from a Cyanobacterial Bloom
Polyphenol Microbial Metabolites Exhibit Gut and Blood–Brain Barrier Permeability and Protect Murine Microglia against LPS-Induced Inflammation
Michelle Glass, Ph.D.
University of Octago profile: https://www.otago.ac.nz/phal/people/Profile/?id=2996
*Head of the Department of Pharmacology & Toxicology at the University of Otago.
PUBLICATIONS BY MICHELLE GLASS, Ph.D.:
Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor
Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor.
The pattern of neurodegeneration in Huntington’s disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington’s disease
Cannabinoid receptors and their endogenous agonists
Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor crosstalk?
Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre
Receptor alterations in human neuro-degenerative diseases
Nephi Stella, Ph.D.
*Ph.D. in Molecular Pharmacology and Ph.D. in Molecular Physiology from College de France
*Cannabinoid-based drug researcher
PUBLICATIONS BY NEPHI STELLA, Ph.D.:
ABHD6 inhibition rescues a sex-dependent deficit in motor coordination in the HdhQ200/200 mouse model of Huntington’s disease
ATPS-15 Cannabidiol Reduces Glioma Cells Proliferation and Viability
ATPS-06-Brain-Penetrant Alkylindole Compounds Promote Apoptosis in Glioma Cells Through Microtubule Destabilization
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
Cannabinoid receptors and endocannabinoids: Evidence for new players
Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood
Dual Inhibition of α/β-Hydrolase Domain 6 and Fatty Acid Amide Hydrolase Increases Endocannabinoid Levels in Neurons
Measuring Endocannabinoid Hydrolysis: Refining our Tools and Understanding
Identification of α,β-Hydrolase Domain Containing Protein 6 as a Diacylglycerol Lipase in Neuro-2a Cells
Targeting Astrocytomas and Invading Immune Cells with Cannabinoids: A Promising Therapeutic Avenue
Endocannabinoid signaling and the deteriorating brain
Potential Upstream Regulators of Cannabinoid Receptor 1 Signaling in Prostate Cancer: A Bayesian Network Analysis of Data From a Tissue Microarray
Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters
Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis
Amber Wise, Ph.D.
*Ph.D. in Chemistry from the University of California at Berkeley
*Cannabis compliance and analytical testing expert
PUBLICATIONS BY AMBER WISE, Ph.D.:
Metals in Cannabis Vaporizer Aerosols: Sources, Possible Mechanisms, and Exposure Profiles
Strategies for Nonpolar Aerosol Collection and Heavy Metals Analysis of Inhaled Cannabis Products
Deeper Dive into Extractions: Multiphase CO2 Extractions for Full Spectrum Native Chemical Profiles
Understanding the Science of Cannabis Produce Development
Extraction Basics, Scientifically Speaking
Upstream adverse effects in risk assessment: A model of polychlorinated biphenyls, thyroid hormone disruption and neurological outcomes in humans.
Are Oral Contraceptives Significant Contributors to Estrogenicity of Drinking Water?
Discrete Arrays of Liquid Crystal-Supported Proteolipid Monolayers as Phantom Cell Surfaces
Policy Recommendations for Addressing Potential Health Risks from Nanomaterials in California
Kevin Spellman, Ph.D.
*Ph.D. in Molecular Biology from University of Exeter, University of North Carolina
*Cannabinoid and cannabis phytochemical expert
PUBLICATIONS BY KEVIN SPELLMAN, Ph.D.:
Neurological Activity of Lion’s Mane (Hericium erinaceus)
The identification of a novel SIRT6 modulator from Trigonella foenum-graecum using ligand fishing with protein coated magnetic beads
Clinical Utility of Curcumin Extract 19(2):14-6
Cannabinoid-Opioid Interaction in Chronic Pain.
Detection, characterization, and screening of heme-binding molecules by mass spectrometry for malaria drug discovery
A review of medicinal plants that modulate nitric oxide activity.
The traditional medicine Spilanthes acmella, and the alkylamides spilanthol and undeca-2E-ene-8,10-diynoic acid isobutylamide, demonstrate in vitro and in vivo anti-malarial activity.
The antiplasmodium effects of a traditional South American remedy: Zanthoxylum chiloperone var. Angustifolium against chloroquine resistant and chloroquine sensitive strains of Plasmodium falciparum
Traditional herbal remedies that influence cell adhesion molecule activity.
Development and characterization of immobilized cannabinoid receptor (CB1/CB2) open tubular column for on-line screening.
The influence of bitter, aromatic and pungent medicinal plants on gut function.
Ecological Pharmacy: From Gaia to Pharmacology.
The influence of traditional herbal formulas on cytokine activity
Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MS
Role for PPARγ in IL-2 inhibition in T cells by Echinacea derived undeca-2E-ene-8,10-diynoic acid isobutylamide
The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day
A critical evaluation of drug interactions with Echinacea spp.
Types of Interactions of Plant Metabolites –Synergistic Modes of Interactions
Liver enzyme-mediated oxidation of Echinacea purpurea alkylamides: production of novel metabolites and changes in immunomodulatory activity.
Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators
Philosophy in Phytopharmacology: Ockham’s Razor versus synergy
National policy dialogue to advance integrated health care: Finding common ground-Final report to the Whitehouse
Folate and vitamin B12 status of adolescent girls in northern Nigeria
Shimon Lecht, Ph.D.
*Ph.D. in Pharmacology from the Hebrew University of Jerusalem
*Member, Committee D37 on Cannabis Standards – ASTM International
*Cannabis-based drug R&D expert
Dr. Lecht has authored or co-authored more than 50 publications, which can be viewed here: https://orcid.org/0000-0002-6499-2390
Is there a cannabis scientist missing from this list? Let us know – you can use our CONTACT FORM, or you can message the author via LinkedIn: https://www.linkedin.com/in/russhudson/